Stage IV Endometrial Carcinoma Completed Phase 2 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0028761 (Stage IV Endometrial Carcinoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01005329Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial CancerTreatment